Clinical Trials
3 trialsNCT02742597 2023-03-17
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT02789800 2022-11-03
PACEinMM-QC
Université de Sherbrooke
Phase NA Completed
NCT00035334 2006-02-14
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
Bellus Health Inc. - a GSK company
Phase 2/3 Completed